Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)

Pall Corporation

Continuous processing optimization with smarter tools

Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific

Accelerating the Commercialization of Biosimilar Medicines in India

Sartorius Stedim Biotech

Current Status of Analytical Techniques for Characterization of Protein Stability

Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning

View All Featured Articles

Headline News

AstraZeneca opens $1 billion global research centre in Cambridge Massachusetts that will lift its local workforce by more than 50 per cent


Ubamatamab produces high rate of durable responses in early study of advanced low grade serous ovarian cancer


Sanofi and Regeneron bring four new long acting antibodies into Dupixent partnership in deal worth up to $8 billion


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Viral Safety by Design for Cell and Gene Therapy Products

Presented by Mark Plavsic, Chief Technology Officer at Lysogene and Archie Lovatt, Life Sciences Biosafety Scientific Director at SGS
24th May 2019


Data as an asset – what does this mean to you?

Presented by Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning at The Janssen Pharmaceutical Companies of Johnson & Johnson and Klaus Mauch, CEO at Yokogawa Insilico Biotechnology GmbH
12th April 2022


Laboratory 4.0 Digitalization and IoLT (Internet of Laboratory Things) Strategies to Enrich Industry 4.0

Presented by Terryl Kibodeaux, Director, IT-Business Relationship Management (BRM) Regeneron Pharmaceuticals, Inc. and Aimee Balkenende, Senior Manager, Technical Sales at Thermo Fisher Scientific
10th June 2021


View All Past Webinars

Featured Companies

 

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

 

View All Videos

Technical Papers

Strategy Emerging Markets for Risk Mitigation


Lifetime study for JSR Amsphere A3 – protein A resin


Amsphere TM A3


Read All Technical Papers

Featured Products

Decrease Cleaning Validation Time and Resources


AdvantaPure


Amsphere™ A3 Protein A Resin – JSR Life Sciences


View All Products

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia